'Black Fungus' Complication Adds to India's COVID Woes

BENGALURU (Reuters) - The Indian government has told doctors to look out for signs of mucormycosis or "black fungus" in COVID-19 patients as hospitals report a rise in cases of the rare but potentially fatal infection.

To Bridge The Digital Divide, Biden Administration Launches Vaccine Hotline It's part of the administration's push to get 70% of adults in the U.S. vaccinated with at least one dose by July 4. NPR.org

In the early months of the vaccination campaign, Internet access was essential to the search for a vaccination appointment.

The world may need to learn to live with the virus.

Early in the pandemic, there was hope that the world would one day achieve herd immunity, the point when the coronavirus lacks enough hosts to spread easily. But over a year later, the virus is crushing India with a fearsome second wave and surging in countries from Asia to Latin America.

Experts now say it is changing too quickly, new more contagious variants are spreading too easily and vaccinations are happening too slowly for herd immunity to be within reach anytime soon.

That means if the virus continues to run rampant through much of the world, it is well on its way to becoming endemic, an ever-present threat.

Vaccine deserts: Some countries have no COVID-19 jabs at all N'DJAMENA, Chad (AP) — At the small hospital where Dr. Oumaima Djarma works in Chad's capital, there are no debates over which coronavirus vaccine is the best. There are simply no vaccines at all... AP NEWS

N’DJAMENA, Chad (AP) — At the small hospital where Dr. Oumaima Djarma works in Chad’s capital, there are no debates over which coronavirus vaccine is the best.

Oklahoma secures refund for its hydroxychloroquine stockpile Oklahoma has reached an agreement with a California-based pharmaceutical company to secure a $2.6 million refund for a stockpile of an ineffective drug the state purchased to fight the coronavirus Reid Wilson TheHill

Oklahoma has reached an agreement with a California-based pharmaceutical company to secure a $2.6 million refund for a stockpile of an ineffective drug the state purchased to fight the coronavirus pandemic.